Fintelmann Florian J, Brinkmann Jesaja K, Jeck William R, Troschel Fabian M, Digumarthy Subba R, Mino-Kenudson Mari, Shepard Jo-Anne O
Departments of *Radiology, Thoracic Imaging and Intervention †Pathology, Massachusetts General Hospital, Boston, MA.
J Thorac Imaging. 2017 May;32(3):176-188. doi: 10.1097/RTI.0000000000000265.
The aim of the study was to investigate the natural history of non-small cell lung cancers (NSCLCs) associated with cystic airspaces, including histopathology and molecular analysis.
A total of 34,801 computed tomographic (CT) scans of 2954 patients diagnosed with NSCLC between 2010 and 2015 were evaluated for association with a cystic airspace. Characteristics on serial CT, 18F-fludeoxyglucose positron emission tomography, and pathologic analysis were recorded.
Cystic airspaces were associated with 1% of NSCLC cases (12 men and 18 women; median age, 66 y [range, 44 to 87 y]). Of the total number of patients, 97% had a smoking history. Twenty-four adenocarcinomas, 4 squamous cell carcinomas, and 2 poorly differentiated carcinomas were distributed throughout all lobes and were predominantly peripheral. Some cystic airspaces appeared in previously normal lungs, whereas others were preceded by subcentimeter nodules. Twenty of 30 cases demonstrated increased soft tissue due to wall thickening, increased loculations, enlargement and/or increased attenuation of a mural nodule, or replacement by a mass. 18F-fludeoxyglucose uptake was present if solid components measured >8 mm. Twenty of 30 patients demonstrated >1 cystic lesion or ground-glass nodule, lymphadenopathy, or evidence of prior lung resection. Pathologic analysis revealed that cystic airspaces correspond to a check-valve mechanism, adenocarcinoma superimposed on emphysema, cystification, and adenocarcinoma parasitizing a preexisting bulla. Fourteen of 26 tumors and 64% of adenocarcinomas tested positive for an alteration of KRAS with or without other alterations.
Cystic airspaces preceded by nodules can evolve into NSCLCs. Wall thickening and/or mural nodularity may develop. Location in the periphery of the upper lobes, emphysema, additional cystic lesions or ground-glass nodules, lymphadenopathy, and prior lung cancer should further increase suspicion. Cystic airspaces on CT can be due to a check-valve mechanism obstructing the small airways, lepidic growth of adenocarcinoma in an area of emphysema, cystification of tumor due to degeneration, or adenocarcinoma growing along the wall of a preexisting bulla. KRAS mutations are the predominant genetic alterations.
本研究旨在调查与含气囊肿相关的非小细胞肺癌(NSCLC)的自然病史,包括组织病理学和分子分析。
对2010年至2015年间诊断为NSCLC的2954例患者的34801份计算机断层扫描(CT)进行评估,以确定其与含气囊肿的相关性。记录系列CT、18F-氟脱氧葡萄糖正电子发射断层扫描及病理分析的特征。
含气囊肿与1%的NSCLC病例相关(男性12例,女性18例;中位年龄66岁[范围44至87岁])。所有患者中97%有吸烟史。24例腺癌、4例鳞状细胞癌和2例低分化癌分布于所有肺叶,且主要位于周边。一些含气囊肿出现在先前正常的肺中,而另一些之前有小于1厘米的结节。30例中有20例因壁增厚、分隔增加、壁结节增大和/或密度增加或被肿块取代而显示软组织增加。如果实性成分测量值>8毫米,则存在18F-氟脱氧葡萄糖摄取。30例患者中有20例显示有>1个囊性病变或磨玻璃结节、淋巴结病或既往肺切除的证据。病理分析显示,含气囊肿对应于单向活瓣机制、叠加在肺气肿上的腺癌、囊肿形成以及寄生于先前存在的肺大疱的腺癌。26例肿瘤中有14例以及64%的腺癌检测出KRAS改变呈阳性,伴或不伴其他改变。
先有结节的含气囊肿可演变为NSCLC。可能会出现壁增厚和/或壁结节。位于上叶周边、肺气肿、额外的囊性病变或磨玻璃结节、淋巴结病以及既往肺癌应进一步增加怀疑。CT上的含气囊肿可能是由于单向活瓣机制阻塞小气道、腺癌在肺气肿区域的鳞屑样生长、肿瘤退变导致的囊肿形成或腺癌沿先前存在的肺大疱壁生长。KRAS突变是主要的基因改变。